Kerwin, E., Hébert, J., Gallagher, N., Martin, C., Overend, T., Alagappan, V. K., . . . Banerji, D. (2012). Efficacy and safety of NVA237 versus placebo and tiotropium in patients with COPD: The GLOW2 study. European Respiratory Society.
Citação norma ChicagoKerwin, Edward, Jacques Hébert, Nicola Gallagher, Carmen Martin, Tim Overend, Vijay K.T Alagappan, Yimeng Lu, and Donald Banerji. Efficacy and Safety of NVA237 Versus Placebo and Tiotropium in Patients With COPD: The GLOW2 Study. European Respiratory Society, 2012.
MLA citiranjeKerwin, Edward, et al. Efficacy and Safety of NVA237 Versus Placebo and Tiotropium in Patients With COPD: The GLOW2 Study. European Respiratory Society, 2012.
Opozorilo: Ti citati niso vedno 100% točni.